Fig. 2From: A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastasesDevelopment of a splenic transplantation of primary tumor-derived organoids to mimic liver metastases Representative CEA, Ki67, EGFR, ERBB2, VEGF, VEGFR2 and CK7 staining of a donor primary tumor, donor liver metastases, organoids, splenic xenografts, and xenografted liver metastases in patient #1 caseBack to article page